Member Board Of Directors @ (April 2022 - Present)
Member Board of Directors @ (February 2022 - Present)
Board of Directors @ (July 2026 - Present)
Board Observer @ (December 2021 - July 2026)
Board of Directors @ (August 2021 - Present)
Board Of Directors @ (May 2019 - Present)
Board of Directors @ (January 2021 - Present)
Board observer @ (November 2018 - January 2021)
Board Observer @ (August 2024 - August 2026)
Board Of Directors @ (May 2019 - January 2025)
Board Of Directors @ Adapsyn Biosciences (April 2019 - June 2024)
Member Board Of Directors @ (March 2021 - October 2021)
Board Observer @ (April 2019 - December 2020)
Board Of Directors @ (May 2019 - August 2020)
Board Observer @ (November 2018 - May 2019)
Board Observer @ Petra Pharma Corporation (January 2019 - March 2020)
Board Observer @ (November 2018 - July 2019)
Chris O'Donnell Education
UC Irvine
Post Doc (Organic Chemistry)
University of Wisconsin-Madison
PhD (Organic Chemistry)
University of Illinois Urbana-Champaign
Bachelor of Science - BS (Organic Chemistry)
Chris O'Donnell Skills
ADME
Analytical Chemistry
Biomarkers
Biopharmaceuticals
Biotechnology
Board Governance
Board Level
Board level experience
CRO
Chemistry
Chromatography
Clinical Development
DMPK
Directorship
Drug Design
Drug Development
Drug Discovery
Drug Metabolism
HPLC
LC-MS
Lead Change
Life Sciences
Lifesciences
Medicinal Chemistry
Oncology
Organic Chemistry
Organic Synthesis
Pharmaceutical Industry
Chris O'Donnell Summary
Chris O'Donnell, based in United States, is currently a Vice President - Business Development and Partner, Pfizer Ventures at Pfizer. Chris O'Donnell brings experience from previous roles at Cartography Biosciences, TRexBio, Arrakis Therapeutics and Pfizer. Chris O'Donnell holds a Post Doc in Organic Chemistry @ UC Irvine. With a robust skill set that includes ADME, Analytical Chemistry, Biomarkers, Biopharmaceuticals, Biotechnology and more. Chris O'Donnell has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Chris O'Donnell?
Find contact details for 700 million professionals.